ICSA-15-174-01
·
Published 2025-06-06
·
View on CISA ICS-CERT ↗
Hospira Symbiq Infusion System Vulnerability
CVSS 8.8
HIGH
CVEs (1)
Remediations
- Hospira has provided compensating measures to help mitigate risks associated with this vulnerability. As previously announced by Hospira in 2013, the Symbiq Infusion System would be retired on May 31, 2015, and will be fully removed from the market by December 2015.
Affected Vendors
Hospira
Affected Products (1)
Hospira
·
Symbiq Infusion System
<=3.13
Get alerted to advisories like this
OTWarden monitors CISA, BSI, Siemens, Rockwell and more — and emails you within 2 hours when your vendors are affected.
Start free trial Learn more